Acadia Healthcare (NASDAQ:ACHC) Earns “Market Perform” Rating from Leerink Partners

Acadia Healthcare (NASDAQ:ACHC)‘s stock had its “market perform” rating reaffirmed by analysts at Leerink Partners in a research note issued to investors on Wednesday, MarketBeat Ratings reports. They currently have a $14.00 price objective on the stock, down from their prior price objective of $25.00. Leerink Partners’ price target would suggest a potential downside of 4.37% from the company’s previous close.

A number of other equities research analysts also recently issued reports on the stock. KeyCorp lowered their price target on shares of Acadia Healthcare from $30.00 to $25.00 and set an “overweight” rating on the stock in a report on Wednesday. Cantor Fitzgerald decreased their target price on shares of Acadia Healthcare from $25.00 to $22.00 and set a “neutral” rating on the stock in a report on Friday, November 7th. Barclays cut their price target on shares of Acadia Healthcare from $20.00 to $17.00 and set an “equal weight” rating for the company in a report on Thursday, November 6th. Cowen reaffirmed a “buy” rating on shares of Acadia Healthcare in a report on Thursday, August 7th. Finally, Weiss Ratings reiterated a “sell (d)” rating on shares of Acadia Healthcare in a research report on Wednesday, October 8th. Eight investment analysts have rated the stock with a Buy rating, six have given a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $23.17.

Acadia Healthcare Trading Down 0.3%

NASDAQ:ACHC opened at $14.64 on Wednesday. Acadia Healthcare has a 1 year low of $12.63 and a 1 year high of $47.08. The stock’s fifty day moving average price is $20.86 and its two-hundred day moving average price is $21.79. The company has a debt-to-equity ratio of 0.73, a current ratio of 1.44 and a quick ratio of 1.44. The company has a market cap of $1.35 billion, a P/E ratio of 12.51, a P/E/G ratio of 3.13 and a beta of 0.91.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings results on Wednesday, November 5th. The company reported $0.72 earnings per share for the quarter, beating the consensus estimate of $0.71 by $0.01. Acadia Healthcare had a return on equity of 7.66% and a net margin of 3.29%.The company had revenue of $851.57 million during the quarter, compared to analysts’ expectations of $852.43 million. During the same period in the previous year, the business earned $0.91 earnings per share. The firm’s quarterly revenue was up 4.4% compared to the same quarter last year. Acadia Healthcare has set its FY 2025 guidance at 2.350-2.450 EPS. As a group, analysts expect that Acadia Healthcare will post 3.38 EPS for the current year.

Institutional Investors Weigh In On Acadia Healthcare

A number of large investors have recently added to or reduced their stakes in ACHC. Caitong International Asset Management Co. Ltd lifted its stake in Acadia Healthcare by 11,218.2% during the first quarter. Caitong International Asset Management Co. Ltd now owns 1,245 shares of the company’s stock worth $38,000 after purchasing an additional 1,234 shares during the last quarter. Allworth Financial LP raised its holdings in shares of Acadia Healthcare by 676.4% during the 2nd quarter. Allworth Financial LP now owns 1,351 shares of the company’s stock valued at $31,000 after buying an additional 1,177 shares in the last quarter. EverSource Wealth Advisors LLC lifted its position in Acadia Healthcare by 54.8% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock worth $32,000 after buying an additional 497 shares during the last quarter. Hantz Financial Services Inc. boosted its stake in Acadia Healthcare by 501.9% in the third quarter. Hantz Financial Services Inc. now owns 2,185 shares of the company’s stock worth $54,000 after buying an additional 1,822 shares in the last quarter. Finally, Covestor Ltd boosted its stake in Acadia Healthcare by 56.0% in the first quarter. Covestor Ltd now owns 2,262 shares of the company’s stock worth $69,000 after buying an additional 812 shares in the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.